False Unicorn Root

What is False Unicorn Root?

United Plant Savers lists false unicorn root (Chamaelirium luteum) as Critical and says it should not be wild harvested or purchased under any circumstance. The conservation nonprofit created that tier in its 2022 list revision and reserves it for species that are federally or state protected or at very high risk of extinction. False unicorn shares it with peyote, Venus flytrap, sundews, trilliums and lady's slipper orchids.

The plant is a small perennial of the Melanthiaceae, native to eastern North America, roughly from Florida to southern New England and west to the Mississippi valley. It grows a flat rosette of leaves and, in late spring, a slender flowering wand. Every plant is either male or female, and only females set seed. In one wild population analyzed by Chakraborty, Meagher and Smouse in Genetics in 1988, 2,255 offspring traced back to a parent pool of 273 males and just 70 females. The part sold is the rhizome, a knobbly piece of underground stem generally under 3 inches long, and digging it kills the plant.

That rhizome goes into tinctures, capsules and multi-herb "women's" formulas sold for fertility, menstrual regularity and, historically, for preventing miscarriage. Those claims trace back through 19th century Eclectic medical texts. No controlled trial I could find has tested any of them.

Common Names

False unicorn, false unicorn root, fairy wand (or fairywand), blazing star, devil's bit, helonias, helonias root, starwort, drooping starwort, unicorn root and star grub root. Botanical synonyms include Helonias dioica Pursh, Helonias lutea Aiton and Veratrum luteum L., the name under which Linnaeus first described it before Asa Gray moved it to Chamaelirium. Homeopathic products still use "Helonias dioica." Four other plants share pieces of this vocabulary and are not the same thing: Aletris farinosa, now usually called true unicorn root, colic root or star grass; Helonias bullata, swamp pink, which the US Fish and Wildlife Service listed as federally threatened on September 9, 1988; the Liatris species of gardens, also sold as blazing star; and the European devil's bit scabious, Succisa pratensis.

Primary Active Compounds

• Steroidal saponins of an unusual type. Challinor and colleagues at the University of Queensland isolated 15 steroidal glycosides from the roots and reported in the Journal of Natural Products in 2012 that 12 appear to be unique to this species, 8 of them previously undescribed.

• Chiograsterol aglycones. The same group (Matovic and colleagues, Chemistry, 2011) fixed the structure of the major saponins by synthesizing their aglycone, 23R,24S-chiograsterol B, from pregnenolone in 16 steps at 1.6 percent overall yield.

• Helosides A and B, built on a previously unknown aglycone the authors named helogenin (Challinor, 2011).

• Cholestane glycosides and sterols. Yokosuka, Takagi and Mimaki at Tokyo University of Pharmacy and Life Sciences reported 6 new cholestane glycosides and 2 new sterols from the underground parts (Journal of Natural Medicines, 2013).

• Chamaelirosides A and B, the open-chain steroidal saponins used as marker compounds in a 2026 authentication method from the University of North Carolina Wilmington.

• Chamaelirin, the historical "bitter principle" that F. V. Greene isolated in 1878, according to the 1918 Dispensatory of the United States. A 2011 paper in Experimental Biology and Medicine repeats an older estimate that the root holds about 10 percent of this saponin, formula C36H62O18.

• Diosgenin appears in secondary monographs. A 2025 review in Chemistry and Biodiversity gives about 2.5 percent of dry weight; I could not trace that figure to a primary measurement among the PubMed-indexed Chamaelirium papers.

Key Note

There is no pharmacopeial standard, no marker-compound specification and, per the 2026 Wilmington paper, no commercial reference standard for this root. There is no clinically tested dose. There is a conservation designation recommending against buying it at all.

The rest of this issue covers what the evidence actually holds, where the supply comes from, and why a herb sold to people trying to conceive is labeled not to be used in pregnancy.

Primary Functions & Benefits

False unicorn root has no established physiological function in humans and no benefit demonstrated in a controlled study. What it has is a list of claimed functions, and each can be checked against what has actually been measured.

Claimed: uterine tonic and fertility support. No human study I found has measured ovulation, conception, cycle length, luteal progesterone or live birth in anyone taking it. The closest data come from the menopause trial. Reed and colleagues reported in Menopause in 2008 that after 12 months, none of the herbal arms, including the two receiving the false unicorn multibotanical, changed vaginal epithelium, endometrium, estradiol, follicle-stimulating hormone, luteinizing hormone or sex hormone-binding globulin. Hormones were measured in 133 postmenopausal women, so this says nothing direct about a 30 year old trying to conceive. It does mean the one time anyone measured reproductive hormones in people given a product labeled to contain false unicorn, nothing moved, though testing did not detect the root in those capsules (Section 4).

Claimed: preventing miscarriage. This is the oldest claim, stated in 1854 and repeated through 1919, and I found no trial of any size that tested it.

Claimed: easing menstrual problems, ovarian cysts and morning sickness. The Natural Medicines content reproduced on RxList files all of these under "Insufficient Evidence to Rate."

Measured in the laboratory. Isolated saponins and their aglycones kill cancer cells in culture: Yokosuka's group reported half-maximal inhibitory concentrations of 6.2 to 15.3 micromolar against HL-60 human leukemia cells for five compounds, and Challinor's 2012 paper found antiproliferative activity in six human tumor cell lines. In 2011, a University of Kalyani group in India reported that a Helonias dioica preparation at 100 and 200 milligrams per kilogram reduced oxidative damage markers in mice made diabetic with alloxan. None of these is a reason to take a tincture.

Forms & Standardization

No false unicorn product I examined stated a marker-compound percentage, and none could have been checked against a reference standard, because the 2026 Wilmington paper reports that none is commercially available. "Standardization" for this root means, at most, a stated herb-to-solvent ratio. Every number in this section describes a product or a historical text, not an amount anyone has shown to be safe or useful.

Dried rhizome, cut or powdered

Sold loose and in capsules. North Carolina State University extension horticulturist Jeanine Davis and research assistant Alison Dressler, in a 2012 grower profile, describe the rhizomes as small enough that they should be dried whole, first for a day at about 70 degrees Fahrenheit with strong airflow and then at about 100 degrees until dry, and say properly stored dried root keeps two to three years. Loose dried root is the form most easily confused with Aletris (Section 18).

Alcohol extracts (tinctures)

A common single-herb form. Professional Formulas sells a BotaniPure False Unicorn Root extract at a 1:3 ratio in grain alcohol (42 percent on one retailer listing, 40 to 45 percent on another) with purified water, in an 8.4 fluid ounce bottle. The serving on its Fullscript listing is one teaspoon, 4.9 milliliters, and simple arithmetic puts that at about 1.6 grams of root equivalent per teaspoon. The listed suggested use is "only when directed by a healthcare professional," and the pregnancy line reads "If pregnant or breastfeeding, consult a healthcare professional before use." Other single-herb tinctures on the US market include one from Nature's Answer.

Multi-herb "women's" formulas

Herb Pharm's Women's Reproductive Health is the clearest example of how this root moves through formulas. Smallflower's listing, marked sold out, names false unicorn rhizome as the first of six herbs, followed by shatavari root and four others: a berry extract, partridge berry, cramp bark and ginger. Professional Supplement Center's listing for the same product name shows those five companions with no false unicorn at all and a different root in first position, a 649 milligram proprietary blend per 0.7 milliliter serving with no per-herb amounts, and the warning "Do NOT use if you are pregnant or nursing." Neither listing says which formula is current or when the change happened, which is itself the point: a buyer cannot tell from a product name whether the bottle contains false unicorn.

The menopause-trial capsule

The Herbal Alternatives for Menopause (HALT) multibotanical supplied, per day, black cohosh 200 milligrams, alfalfa 400, boron 4, chaste tree 200, dong quai 400, false unicorn 200, licorice 200, oats 400, pomegranate 400 and Siberian ginseng 400. Those are label amounts. ConsumerLab.com tested the products after the study began, and the trial report states that "Dong quai, false unicorn, and pomegranate were not detected," which the authors said suggests they were of poor quality or lacked the tested marker compounds. This is the only preparation labeled as false unicorn with any randomized human data, HALT did not test the 200 milligrams on their own, and it is not certain participants received any.

Homeopathic Helonias

Homeopathic remedies labeled "Helonias dioica" are diluted preparations and should not be confused with herbal extracts. They are listed here only because the name on the box differs from the name on herbal labels.

Historical preparations, for the record only

These figures come from texts that also recommended the root during threatened miscarriage, and they are not doses to use. John King's American Eclectic Dispensatory of 1854 gave 20 to 40 grains of powder (about 1.3 to 2.6 grams) or 2 to 4 fluid ounces of decoction. Felter and Lloyd's King's American Dispensatory of 1898 gave 10 or 15 grains (about 0.65 to 0.97 gram) repeated 3 or 4 times a day, 10 to 30 minims of saturated tincture and 1 to 20 drops of "Specific Helonias." Finley Ellingwood's American Materia Medica of 1919 gave 5 to 30 minims of fluid extract and 2 to 5 grains of "helonin." The 1918 Dispensatory of the United States describes helonin as the alcoholic extract found in commerce and gives the root as a 1 in 16 infusion by the wineglassful. Modern secondary monographs, including Drugs.com's professional entry, repeat a traditional range of 1 to 2 grams of root as tea or 2 to 5 milliliters of tincture three times daily while stating that no clinical study supports any dose.

Food Sources

False unicorn root is not a food and has no dietary source; the only route of exposure is a supplement or herbal preparation. Its folk record points the other way: Felter and Lloyd wrote in 1898 that the plant "is said to kill cattle feeding on it" and that a decoction was used to kill insects, bugs and lice. Neither claim has modern verification, and neither suggests a food.

Who Should Take False Unicorn Root

No group has a trial-supported reason to take false unicorn root, and the conservation body that tracks it recommends against buying it. The people who reach for it are mostly trying to conceive, have had a miscarriage, or are bleeding in early pregnancy, and each of those situations has a better first step than a tincture.

Trying to conceive without success

The American Society for Reproductive Medicine recommends an infertility evaluation after 12 months of trying when the woman is under 35, after 6 months at 35 or older, and earlier still for women over 40 or with known risk factors such as irregular cycles. An evaluation covers ovulation, tubal patency and semen analysis, the last of which no herb sold to women addresses. Months spent on an untested root are months not spent finding out which of those is the problem.

After one or more miscarriages

The same society's 2020 committee opinion defines recurrent pregnancy loss as two or more failed clinical pregnancies, a threshold at which evaluation is reasonable. Workups look for treatable causes such as antiphospholipid syndrome, uterine anomalies, thyroid disease and parental chromosome rearrangements.

Bleeding or cramping in early pregnancy

This is the exact situation Eclectic texts prescribed helonias for, and it is a reason for same-day medical assessment, because the same symptoms can signal an ectopic pregnancy.

Herbalists who still want to work with the plant

United Plant Savers' Critical definition makes exceptions only for research that directly supports the health of wild populations and for sustainable use by Indigenous communities with a traditional connection to the plant. For everyone else the recommendation is simply not to buy it. Root a seller can document as cultivated removes the conservation objection, and none of the evidence or pregnancy objections.

Who Should AVOID or Use Caution

Contraindications

• Being pregnant, at any stage. The Natural Medicines monograph on RxList states that it is "UNSAFE to use false unicorn if you are pregnant." Drugs.com's professional monograph says "Avoid use" and notes reports that extracts have emmenagogue, estrogenic and uterotonic effects.

• Trying to conceive, in any cycle where pregnancy is possible. Conception precedes a missed period by about two weeks, so anything taken after ovulation in a conception cycle is taken during a possible pregnancy.

• Breastfeeding. RxList says not enough is known and advises avoiding it.

• Bleeding, cramping or pain during pregnancy. These need medical evaluation, not a uterine "tonic."

• Stomach or intestinal disorders. RxList states that false unicorn can irritate the stomach and intestines and advises against it for anyone with such problems.

• Lithium therapy. RxList rates the combination a moderate interaction (Section 17).

Use Caution

• Anyone in a fertility treatment cycle with clomiphene, letrozole, gonadotropins or progesterone support. I found no interaction study, which means no one knows, not that the combination is safe.

• Heart disease. F. V. Greene called chamaelirin a cardiac poison when he isolated it in 1878, and Ellingwood wrote in 1919 that "Helonias in large doses is a cardiac poison." No modern study I found has either confirmed or excluded a cardiac effect.

• Anyone avoiding alcohol, including people taking disulfiram or metronidazole and people in recovery. The Professional Formulas extract is listed at 40 to 45 percent alcohol, though some brands use far less.

• Anyone on drugs metabolized by CYP2D6 or CYP3A4, on the strength of a test-tube study only (Section 17).

Critical Safety Point

A herb marketed for fertility will be taken by people who are pregnant or about to be, and the safety record for exactly that use is blank. I found no study of false unicorn in pregnant women, no animal reproductive toxicity study in PubMed, and no pharmacokinetic data showing whether its saponins cross the placenta. Its historical use was precisely during pregnancy, given in "full doses" alongside viburnum for threatened abortion in Ellingwood's 1919 text, and that history is the reason the modern references read the way they do: they cannot rule out a uterine effect, so they rule the herb out. The embryo's organs form in roughly weeks 3 to 8 after conception, much of it before many people know they are pregnant. The safe reading of the labels is literal: if pregnancy is possible this cycle, do not take it, and if you are pregnant and bleeding, go to a clinician.

Recommended Dosages

False unicorn root has no recommended dose. No dose has been tested alone in any human trial I found, for any purpose, and this issue gives none. Historical and label figures appear in Section 4 as product and history facts only.

Dried root and capsules

No tested dose. Capsule labels set their own amounts without any trial behind them.

Tinctures and fluid extracts

No tested dose. Ratios such as 1:3 describe concentration, not safety or effect.

Multi-herb formulas

No tested dose of the false unicorn component, and many proprietary blends do not disclose how much is present.

Homeopathic Helonias

Not an herbal dose in any meaningful sense; outside the scope of this issue.

Duration

No duration of use has been studied for any indication relevant to the label claims. The longest exposure in any trial was 12 months, inside a 10-ingredient capsule, in women aged 45 to 55.

Timing & Administration

No timing advice applies, because there is no tested benefit to optimize. The one timing fact that matters is reproductive, not pharmacological: fertility formulas are often taken daily across the whole cycle, which means through the roughly two weeks between ovulation and an expected period, when a conception may already have happened and cannot yet be detected. That window is the strongest practical argument against "taking it while trying."

Timeline of Effects

No onset, peak or plateau has been documented for any effect of false unicorn root, so there is no fair trial period to wait out. The only timed human data come from the HALT menopause trial, whose capsules tested negative for false unicorn (Section 4), where outcomes were measured at 3, 6 and 12 months. At every time point, the difference between placebo and any herbal arm was less than 1 hot flash or night sweat per day, and averaged across follow-up it was under 0.55 per day. Hormone therapy in the same trial cut symptoms by 4.06 per day against placebo, averaged over follow-up (95 percent confidence interval 2.19 to 5.93). At 12 months, symptom intensity in the multibotanical plus soy-counseling arm was significantly worse than placebo (P = 0.016). The reproductive hormone measurements reported by Reed in 2008 were taken at baseline and 12 months, and no herbal arm showed an effect on any gynecologic outcome at any time point.

Herbal practitioners describe the root as something to take "long-term in small doses," in Christopher Hobbs's phrase. I found no study measuring what long-term use does, good or bad.

For someone trying to conceive, the clock that matters is the clinical one in Section 6: 12 months of trying under 35, 6 months at 35 or older. A bottle of false unicorn should not reset it.

Benefits of Taking False Unicorn Root

No benefit of taking false unicorn root has been demonstrated in a controlled human study. Its reputation is a historical artifact, and the history is worth knowing because it shows how a 19th century uterine "tonic" became a 21st century fertility supplement.

Indigenous use. Modern secondary sources, including the Drugs.com professional monograph, attribute uses for preventing miscarriage, menstrual problems and fertility to Indigenous peoples of eastern North America. I could not locate the primary ethnographic records behind those summaries, so I report them as attributions, not documented practice.

1854: the Eclectic foundation. John King's American Eclectic Dispensatory, a standard text for the Eclectic physicians of the period, wrote that "In uterine diseases it is held to be invaluable," described it as "acting as a uterine tonic," and recommended it "to remove the tendency to repeated and successive miscarriages." Note what is absent: no case counts, no outcomes, no comparison.

1878: a chemist's warning. F. V. Greene isolated the bitter saponin he named chamaelirin and, as the 1918 Dispensatory of the United States records, stated that it is a cardiac poison.

1898: the claims widen. Felter and Lloyd's King's American Dispensatory called it, in diseases of the female reproductive organs, "one of our most valuable agents," noted that some considered it useful "for the relief of the vomiting of pregnancy," and quoted King's experience of "a decidedly beneficial influence in cases of sexual lassitude in both sexes." It also recorded the long-running confusion with Aletris covered in Section 18.

1918: the mainstream reference demurs. The Dispensatory of the United States, edited by Remington and Wood, said only that the drug "is said to be diuretic, tonic, and anthelmintic," without endorsing any uterine use.

1919: threatened miscarriage. Finley Ellingwood's American Materia Medica, Therapeutics and Pharmacognosy recommended, for uterine disorders accompanied by threatened abortion, combining helonias with viburnum "in full doses," and called it useful in impotence, while warning that it is a cardiac poison in large doses.

The word "fertility." None of the three Eclectic entries I read (King 1854, Felter and Lloyd 1898, Ellingwood 1919) recommends the root for sterility, barrenness or infertility; where "barren" or "sterile" appears at all, it describes the plant's own nonseeding flowers. Their claims concern miscarriage, uterine "atony" and libido. The fertility label is a later framing: a modern herbal database by Hobbs calls it "an ovarian adaptogen," and a 2021 United Plant Savers essay by its executive director, Susan Leopold, calls it a "sacred fertility herb" while arguing it should come out of Appalachian commerce.

2006: the only trial I found. HALT, funded by the National Institute on Aging and the National Center for Complementary and Alternative Medicine, put false unicorn on the label of a multibotanical for menopause and found no benefit, and testing did not detect the root in the capsules (Section 4).

Potential Negatives & Side Effects

Nausea and vomiting. Felter and Lloyd described the root as "in large doses, emetic," and RxList states that large doses can cause nausea and vomiting. No dose threshold has been established.

Stomach and intestinal irritation. RxList states that false unicorn can irritate the stomach and intestines. Saponin-rich roots commonly do, but I found no false unicorn study measuring the effect.

Increased salivation from fresh root. Felter and Lloyd called the fresh plant a sialagogue, a substance that increases saliva.

A clotting-factor signal, in combination. Spangler and colleagues analyzed 3-month blood work from 310 HALT participants and reported in Maturitas in 2007 that fibrinogen appeared to rise in the multibotanical group compared with the other herbal groups and placebo overall (P = 0.02), though the pairwise comparison against placebo alone was not significant (P = 0.11). With 10 labeled ingredients, and false unicorn not detected when the capsules were tested, nothing can be pinned on false unicorn.

No excess bleeding, in combination. In Reed's 2008 analysis, abnormal uterine bleeding occurred in 53 of the 313 participants with a uterus (16.9 percent), with no difference between any herbal arm and placebo. For the same testing reason, this is not evidence that the root itself is free of bleeding effects.

Unresolved cardiac question. The 1878 and 1919 statements that chamaelirin and helonias are cardiac poisons have, as far as I could find, never been tested in a modern study. Absence of follow-up is not evidence of safety.

Effects of whatever is actually in the bottle. If, as the 2026 Wilmington analysis found, most products lack false unicorn's chemical profile, the side effects a buyer experiences may belong to a substitute that no one has identified.

Deficiency Symptoms

What False Unicorn Root addresses

No deficiency state exists. Nothing in human physiology requires this plant or its saponins, and no blood test, symptom or diet produces a shortfall. The conditions it is sold against are not deficiencies either. "Uterine atony" in the Eclectic sense is not a modern diagnosis. The nearest modern candidate, luteal phase deficiency, was the subject of a 2021 American Society for Reproductive Medicine committee opinion, reissued in 2026, which defines it clinically as a luteal phase of 10 days or less and states that it "has not been proven to be an independent entity causing infertility or recurrent pregnancy loss," with no agreed method of diagnosis.

Bottom line

There is nothing to replete. A cycle problem that seems to call for a "uterine tonic" calls instead for a diagnosis.

Toxicity Symptoms

At high intake

• Nausea and vomiting, described in both the 1898 Dispensatory and the RxList monograph.

• Stomach and intestinal irritation.

• Historically reported, never quantified: cardiac toxicity, from Greene in 1878 and Ellingwood in 1919.

• Historically reported in animals: Felter and Lloyd's 1898 note that the plant "is said to kill cattle feeding on it."

• Reported in rats: the Drugs.com monograph cites a 1950s study in which toxicity was observed at 40 to 50 milligram doses of dried plant extract. I could not locate the original report.

No human overdose case for false unicorn appeared in my PubMed searches, and I found no human toxicity study there either. That is an absence of data, not a demonstration of safety.

Signs to reduce or stop

Stop immediately on vomiting, abdominal pain, palpitations, an irregular or unusually slow pulse, fainting, or any positive pregnancy test. Any bleeding or cramping in a pregnancy, whether or not the herb is involved, warrants prompt medical evaluation. Bring the bottle, because the label may be the only record of what was taken.

General note

The toxicity picture is thin because, apart from that 1950s rat report, no one appears to have looked, not because someone looked and found nothing. Drugs.com's toxicology section concludes that "False unicorn is not considered safe for consumption," while noting that some toxicity reports may belong to Veratrum species confused with it. RxList's line that it "seems to be safe for most adults" and its line that it is "UNSAFE" in pregnancy rest on the same small base of tradition and reasoning, not on measurement.

How False Unicorn Root Works

No mechanism has been established for any claimed effect, so this section describes what the chemistry and the few experiments show.

The saponins are unusual. The roots are dominated by steroidal glycosides whose side chain stays open, which the 2026 Wilmington authors call a structurally distinctive subclass whose greater flexibility "may confer bioactivities distinct from common steroidal saponin scaffolds." That sets them apart from the closed-ring diosgenin family. The De Voss group's synthesis of 23R,24S-chiograsterol B in 2011 was needed precisely because the stereochemistry of these molecules could not be settled by spectroscopy alone. Beyond cell culture, I found no biological testing of any of these compounds.

Diosgenin does not become a hormone in the body. Secondary sources list diosgenin among the root's constituents, and marketing sometimes implies a "hormone precursor." Chemists can turn diosgenin into steroid hormones in a factory; the human body cannot, the same point that applies to wild yam. A root's diosgenin content, whatever it is, does not make it hormonal.

Hormones did not move in the one human measurement. Reed's 2008 HALT analysis found no change in estradiol, follicle-stimulating hormone, luteinizing hormone or sex hormone-binding globulin after 12 months on the multibotanical labeled with false unicorn, a product in which testing did not detect the root.

Cell and animal effects are at concentrations not linked to any human dose. The cytotoxic saponins and aglycones act at 6.2 to 15.3 micromolar in leukemia cells. I found no human pharmacokinetic data at all: no measurement of whether these glycosides are absorbed, what blood levels follow a tincture dose, or how long they persist. In 2003, Ng and Figg at the National Cancer Institute reported that five multi-herb supplements whose ingredient pool included false unicorn inhibited human prostate tumor xenografts in mice by 53 to 87 percent, but no single-herb effect can be read from mixtures.

Saponins and the gut. Saponins are surface-active, soap-like molecules, which is the most plausible explanation for the nausea, vomiting and gut irritation the references describe. I found no test of that for this root specifically.

Uterine action is asserted, not measured. Drugs.com cites reports of uterotonic and emmenagogue activity, and the Eclectic texts assumed a "tonic" action on uterine muscle. My PubMed search pairing the plant's names with "uterine" returned nothing, so whether the root contracts, relaxes or ignores uterine muscle is unknown. For a product taken around conception, that unknown is the whole problem.

Synergistic Supplements

None demonstrated. No combination containing false unicorn has outperformed placebo in any trial I found, and the one tested combination did not. Historical pairings exist as history: Ellingwood in 1919 combined helonias with viburnum for threatened miscarriage and, elsewhere in the same entry, with Aletris farinosa, which shows that even an Eclectic author treated the two "unicorn" roots as separate drugs. Modern formulas pair it with shatavari root, partridge berry (Mitchella repens) and cramp bark (Viburnum opulus). On the Herb Pharm listing quoted in Section 4, both partridge berry and cramp bark are labeled "responsibly wildcrafted," so swapping false unicorn for a formula of its usual companions does not necessarily take a buyer out of wild-harvested supply.

Interactions & What NOT to Take

Lithium. The Natural Medicines monograph on RxList rates this a moderate interaction, on the grounds that false unicorn may slow lithium excretion and so push blood lithium levels up. The reasoning follows the root's traditional reputation as a diuretic. No pharmacokinetic study confirms it, and lithium's narrow therapeutic range makes even a theoretical change worth avoiding.

Drugs cleared by CYP2D6 or CYP3A4. Ho and colleagues at McMaster University tested commercial preparations of four herbal products marketed to women, false unicorn among them, against human drug-metabolizing enzymes in the test tube and reported in Phytotherapy Research in 2011 that every preparation inhibited some enzymes at potencies around 1 microgram per milliliter. Drugs.com's summary names CYP2D6 and CYP3A4 for false unicorn. The authors noted that components of the products interfered with the assays and that only appropriate in vivo studies could show whether the effect matters clinically. I found no such study.

Clomiphene, specifically. This is the interaction the target buyer is most likely to face, and it is theoretical. Clomiphene citrate, which Mürdter and colleagues describe as the most used drug for female infertility, depends on metabolic activation: they showed in Human Molecular Genetics in 2012 that CYP2D6 forms its two most active metabolites, and that women with nonfunctional CYP2D6 genes reached peak levels of those metabolites 8 and 12 times lower. A product that inhibits CYP2D6 in the test tube, taken alongside clomiphene, could in principle blunt the drug. I found no study testing it. Tell the prescribing clinician about any herb taken during a treatment cycle.

Letrozole, gonadotropins and progesterone support. I found no interaction data for any of them with false unicorn.

Alcohol-sensitizing drugs. A 4.9 milliliter teaspoon of a 42 percent alcohol extract contains about 2 milliliters of ethanol, roughly 1.6 grams, about a ninth of a US standard drink. That is small, but it is not zero for someone taking disulfiram or metronidazole, and it is not zero in pregnancy.

What not to take. Any false unicorn product during pregnancy, while breastfeeding, or in a cycle in which you may conceive. Any multi-herb fertility formula whose label does not state whether false unicorn is present and in what amount. Any loose root sold without identity testing, given the documented history of Aletris substitution.

Quality, Testing & Adulteration

Most products tested did not match. In October 2026, Sarah Barr, Wilmer Perera of CAMAG Scientific and Wendy Strangman of the University of North Carolina Wilmington published in the Journal of Natural Products an authentication workflow combining high-performance thin-layer chromatography fingerprints with liquid chromatography-mass spectrometry metabolomics, using chamaelirosides A and B as markers. They built reference profiles from authenticated C. luteum material and then ran purchased commercial products. In the abstract's words, "The majority of products lacked characteristic C. luteum profiles, highlighting species substitution and adulteration." The abstract does not give the number of products or name the brands, and the publisher page was not available to me.

The substitution is more than 170 years old. King's 1854 Dispensatory reported "much difficulty among druggists and herb-gatherers in determining the difference between the roots of Aletris Farinosa and Helonias Dioica," adding that "these roots have been indiscriminately bought and sold." Felter and Lloyd in 1898 said the root "has long been confounded with, and sold for, that of Aletris farinosa," and repeated the earlier warning that roots from one region would be labeled the reverse of those from another. Their own naming shows how deep the tangle ran: they wrote that "unicorn root" originally meant Chamaelirium and was "afterward" applied to Aletris, "which is thus the False unicorn." Today's convention runs the other way, with Aletris as "true unicorn" and Chamaelirium as "false unicorn." A 2015 paper in Chemical Science from the University of Queensland group states that the two plants have "been used interchangeably within herbal medicines."

The two roots are chemically distinct, so a lab can tell them apart. Chamaelirium is built around steroidal glycosides. The major constituent of Aletris farinosa, Challinor and colleagues reported in the Journal of Natural Products in 2013, is a cheilanthane sesterterpene, a different class of molecule entirely. A competent chromatographic fingerprint separates them; a visual inspection of cut, dried root may not.

What third-party programs can and cannot do here. Contaminant panels for heavy metals, microbes and pesticides work the same for this root as for any other. Identity testing is the weak point: per the 2026 paper, no commercial reference standard for C. luteum exists, so a certificate stating "identity confirmed" invites the question of confirmed against what.

Origin is invisible. None of the false unicorn labels or listings I examined stated whether the root was cultivated or wild. The Professional Formulas listing says only that "organic or wild harvested sources are utilized whenever possible."

What a buyer can find out before paying. Ask the seller three things in writing: whether the root was grown on a farm, and which one; what method confirmed the species, and specifically whether it was compared with authenticated Chamaelirium reference material and checked against Aletris; and how much false unicorn is in each serving if the product is a blend. A seller who cannot answer the first question is, by the arithmetic in Section 19, most likely selling wild root. A seller who cannot answer the second is selling a name.

Special Considerations

Labels disagree about pregnancy. The Herb Pharm formula label quoted in Section 4 says "Do NOT use if you are pregnant or nursing," but that is the version listing dong quai and no false unicorn. The Professional Formulas single-herb extract says "If pregnant or breastfeeding, consult a healthcare professional before use." RxList's monograph says it is "UNSAFE" in pregnancy. The softest of these instructions appears on the single-herb extract, the bottle with the most false unicorn in it.

Threatened miscarriage has been studied properly, with a hormone, and the result is sobering. The PRISM trial randomized 4,153 women with bleeding in early pregnancy at 48 UK hospitals to vaginal progesterone 400 milligrams twice daily or placebo through 16 weeks, and reported in the New England Journal of Medicine in 2019 live births after at least 34 weeks in 75 percent (1,513 of 2,025) versus 72 percent (1,459 of 2,013), a relative rate of 1.03 with P = 0.08. That is a prescription drug, given under supervision, studied in thousands of women, and its overall effect was small enough to fall short of statistical significance. In a subgroup analysis, women with three or more previous miscarriages had live births in 72 percent on progesterone versus 57 percent on placebo, and in November 2021 the UK's NICE guideline NG126 began recommending vaginal micronized progesterone for early pregnancy bleeding after a previous miscarriage. The herb Eclectic physicians gave for the same situation does not appear in any trial I could find. Bleeding in pregnancy belongs with a clinician who can confirm where the pregnancy is and whether it is viable.

Fertility treatment. Anyone in an ovulation-induction or IVF cycle is on precisely timed drugs, has frequent blood tests and may be pregnant without knowing it. Add nothing untested, and list every supplement for the clinic.

Breastfeeding. No data. RxList advises avoiding it.

Adolescents. No pediatric data exist, and an irregular cycle in the first years after a first period is common and often normal. That is a question for a pediatrician or gynecologist, not a reason to start an adult women's formula.

Conservation and supply. Every bottle draws on a slow plant, and the numbers show why United Plant Savers placed it in its top tier.

• Harvest kills the plant. Chip Carroll of the Rural Action research center in Ohio, writing for United Plant Savers in 2011, put it plainly: harvesting the rhizome kills the entire plant.

• Time to harvest. Carroll calls it "generally thought to be a 6-8 year crop from seeds or cuttings"; the 2012 North Carolina State profile says transplants should be ready four to six years after planting and that wild-dug roots typically come from plants four to eight years old. Carroll also reports an Ohio study by Amy Brush in 2005 in which beds planted in 2000 produced roots that had stayed the same size or shrunk after five years.

• Only females make seed, and in at least one natural population the seed parents were outnumbered roughly 4 to 1 (Section 1).

• Wild share. The North Carolina State profile puts the wild-harvested share at about 80 percent for 2003 to 2005, when consumption ran roughly 6,200, just under 5,000 and 6,000 pounds a year. Carroll cites a 2001 wild harvest of 13,500 pounds. Virginia Tech's Root Report, a survey of registered ginseng dealers by Steve Kruger and John Munsell, recorded annual trade of 6,143 dry pounds of false unicorn for 2014 to 2015, at an average 2015 price to harvesters of 72.14 dollars a pound (443,156 dollars in total), and states that apart from a small share of goldenseal, everything those dealers bought was wild-harvested.

• Plants per pound. Leopold's 2021 essay estimates roughly 75 plants to a pound of root, more if the roots are dried. Applying that rough figure to the Root Report total, my arithmetic, gives at least 460,000 plants a year from that one dealer network, since the Root Report counts dry pounds.

• State protection. Massachusetts lists it as Endangered, with four recent verified and three historical occurrences, per a state fact sheet published April 10, 2025. Connecticut lists it as endangered, per the Native Plant Trust's Go Botany. Indiana's October 29, 2025 list ranks it state endangered and S1, critically imperiled in the state. United Plant Savers lists it as threatened in New York.

• Global status. Indiana's same list gives a global rank of G4G5, meaning apparently secure to secure across its whole range. The problem is not that the species is about to vanish everywhere; it is that collection concentrates on wild populations of a slow, dioecious perennial, and the plant's scarcity at the edges of its range shows how little cushion some populations have.

• Prices. North Carolina State reports harvester prices of 25 to 35 dollars a pound in 1995 to 1999, a high of 85 dollars in 2007, and seed selling for over 200 dollars an ounce. Leopold found dried root listed on Etsy in 2021 at 40 dollars a gram.

• United Plant Savers' species assessment page gives an overall at-risk score of 49.

Research Status & Evidence Quality

Tier 1, randomized evidence. One trial, and not of false unicorn alone. HALT (Newton and colleagues, Annals of Internal Medicine, 2006; trial NCT00169299) randomized 351 women aged 45 to 55 with at least two hot flashes or night sweats a day to five arms for 12 months. The two multibotanical arms, each containing 200 milligrams a day of false unicorn among 10 ingredients, did not differ from placebo on symptom frequency, intensity or the Wiklund vasomotor subscale. Secondary analyses found no effect on reproductive hormones, endometrium or bleeding (Reed, 2008) and no effect on lipids, glucose or insulin, with an unresolved fibrinogen signal (Spangler, 2007). The authors noted that differences under 1.5 symptoms a day could not be ruled out, and ConsumerLab.com testing after the study began did not detect false unicorn in the multibotanical.

Tier 2, other controlled human studies. None found.

Tier 3, laboratory and animal work. Structural chemistry from the University of Queensland (2011, 2012) and Tokyo (2013); cytotoxicity in cancer cell lines; one mouse study of a Helonias dioica preparation in chemically induced diabetes (Chakraborty, 2011); one mouse xenograft study of mixtures (Ng and Figg, 2003); one test-tube enzyme study of a commercial preparation (Ho, 2011); and the 2026 authentication method.

Tier 4, tradition only. Fertility, miscarriage prevention, menstrual regulation, ovarian cysts, morning sickness and libido. These rest on 19th and early 20th century texts that report no outcomes.

Research Limitations

A PubMed search on October 26, 2026 for Chamaelirium, helonias or "false unicorn" returned 18 records, several of them plant genetics, evolution or papers on a different Helonias species, and none was a trial of the herb alone. Adding pregnancy, miscarriage, fertility, infertility, abortion or uterine to that search returned none. I found no human pharmacokinetic data, no dose-finding work and no validated standardized extract, so even a well-designed trial would first have to decide what to give. A 2025 review in Chemistry and Biodiversity reports round percentages for diosgenin, gallic acid and quercetin that I could not match to a primary analysis. I found no modern examination of the historical claims of cardiac toxicity. And with the majority of commercial products in the 2026 analysis failing to show the species' chemical profile, any future observational report on "false unicorn users" would have to establish first that they had taken false unicorn.

Summary & Key Takeaways

Bottom Line

False unicorn root is sold for fertility on the strength of Eclectic texts from 1854 to 1919 that promised to prevent miscarriage and tone the uterus without measuring any outcome, and the three I read do not recommend it for infertility at all. The only human trial I found is one menopause study in which it was one labeled ingredient of 10, testing did not detect it in the capsules, and the product failed. Most of the supply is dug from the wild, each dig kills a plant that takes years to replace, and in 2026 most commercial products tested did not chemically match the species on the label.

Key Safety Points

• Do not take it if you are pregnant, may become pregnant this cycle, or are breastfeeding. Its traditional use was during pregnancy, and I found no safety data for that use.

• Bleeding or cramping in pregnancy needs same-day medical assessment.

• Large doses cause nausea and vomiting; 19th century authors also called it a cardiac poison, a claim I found no modern test of.

• Lithium users should avoid it; anyone on clomiphene or other fertility drugs should tell their clinic before adding any herb.

• Product identity is unreliable, and labels disagree on whether pregnant women should use it at all.

Special Note

"Unicorn root" has meant two different plants in two different centuries, and the label on a modern bottle cannot settle which one is inside without a laboratory. What a buyer can settle is the larger question: whether a slow wild lily, on a conservation list that recommends against buying it, is a sensible thing to take into the most medically sensitive weeks of a person's life on the basis of 19th century assurances. The evidence assembled here points to no.

Researched and drafted with AI assistance. Every claim verified against primary sources and human-reviewed before publication. Last reviewed: October 26, 2026. Corrections: reply to any issue.

This page informs; it does not diagnose or prescribe. Anyone pregnant, trying to conceive, on prescription medication or managing a diagnosed condition should check with their own clinician before starting, stopping or changing anything.